Thailand plans November human testing for potential coronavirus vaccine

Henrietta Strickland
July 13, 2020

The first group, aged 18 to 60, will receive different doses of the vaccine, he said.

According to a report by TASS, the Russian defence ministry said that "an in-ward treatment of the first group of volunteers, who were tested for the safety and tolerability of the vaccine, will end on 15 July". Till now only a Chinese vaccine by CanSino Biological Inc has been approved for use on the military for a period of one year. "In biotechnology, it is a rare phenomenon for everything to go perfectly", Schelkanov said.

"In 2009, Thailand failed to secure swine flu vaccine in time due to the drug's limited production run, even though it was paid for in advance". Sinovac and Instituto Butantan are developing one which is at the Phase III stage.

As the world races to come up with an effective vaccine against Covid-19, Russian Federation has become the first country to successfully complete clinical trials of Covid-19 vaccine on humans.

After Russia became the first country to successfully conclude human trials for the world's premier coronavirus vaccine, India is set to begin the human clinical trials for vaccines against the SARS-CoV-2, the virus that causes the dreaded coronavirus disease (COVID-19).

The objective of the trial was to study whether the vaccine is safe for human health which showed positive results, said Alexander Lukashev, Director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases of Sechenov University.

The research team - led by Kiat Ruxrungtham of the Chula Vaccine Research Centre - made the remark at a press conference charting progress in their work. Around 800 people will be administered the vaccine. The British drugmaker has started conducting pPase 3 human trials of its AZD1222 (formerly known as ChAdOx1 nCoV-19) vaccine candidate.

Earlier, results of the COVID-19 vaccine tests performed on a group of volunteers in Russian Federation showed that they were developing immunity to the coronavirus.

It comes two months after pre-clinical tests produced promising results, with test subjects' antibody responses appearing to be better than responses in recovered COVID-19 patients who hadn't had the vaccine.

After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days.

As of July 12, there were 9797 confirmed coronavirus cases reported in Australia since January 22 2020.

Other reports by Click Lancashire

Discuss This Article